Friday, December 7, 2012- The Nasdaq Now: Warning Shots Fired for Smith & Wessonat Minyanville (Fri, Dec 7)
- Alexion Pharmaceuticals and Other Big Movers on the Nasdaq on December 7, 2012at Investopedia (Fri, Dec 7)
- Midday Movers: CSCO, CTXS & Moreat CNBC (Fri, Dec 7)
- Amarin's Stock Drops on Plan to Sell Heart Drug Vascepa Aloneat Minyanville (Fri, Dec 7)
- PowerShares QQQ Trust and Amarin Corporation Among Most Active Stocks in Nasdaq Pre-Marketat Minyanville (Fri, Dec 7)
- The Worst Biotech CEO of 2012 Is...at TheStreet (Fri, Dec 7)
- Stock Futures Rise After Strong Jobs Reportat TheStreet (Fri, Dec 7)
- Amarin tanks on plan for sales forceoptionMONSTER (Fri, Dec 7)
- Amarin's Sad And Lonely Vascepa Launch Party (Updated)at TheStreet (Fri, Dec 7)
- Amarin allowed key ANCHOR '520 patent, says Jefferiestheflyonthewall.com (Fri, Dec 7)
- Morning Briefing: 10 Things You Should Knowat TheStreet (Fri, Dec 7)
- Stocks to Watch: Netflix, Palo Alto Networks, AmarinTheStreet (Fri, Dec 7)
- Amarin Corporation Drops A Double Dose Of Bad Newsat Seeking Alpha (Fri, Dec 7)
- The Price May Be Increasing For An Amarin Buyoutat Seeking Alpha (Fri, Dec 7)
Thursday, December 6, 2012 Wednesday, December 5, 2012 Tuesday, December 4, 2012 Sunday, December 2, 2012 Saturday, December 1, 2012Add AMRN News to My Yahoo!  | |
|